Skip to content

Topics: Health, Health Care, Pharmaceuticals

  • Mobile app reduces post-traumatic stress

    Support offered by a phone app can relieve post-traumatic stress and depression. A new study from Uppsala University’s National Centre for Disaster Psychiatry involving 179 patients shows that a dedicated PTSD app, PTSD Coach, helps adults suffering from mental health issues after traumatic events.

  • More chemicals, fewer words: exposure to chemical mixtures during pregnancy alters brain development

    By linking human population studies with experiments in cell and animal models, researchers have provided evidence that complex mixtures of endocrine disrupting chemicals impact children’s brain development and language acquisition. With their novel approach, the scientists show that up to 54 per cent of pregnant women were exposed to experimentally defined levels of concern.

  • Ancestors of legionella bacteria infected cells two billion years ago

    Researchers at Uppsala University have discovered that the ancestors of legionella bacteria infected eukaryotic cells as early as two billion years ago. It happened soon after eukaryotes began to feed on bacteria. These results, described in a new study published in Molecular Biology and Evolution, also contributes to the chicken-or-egg debate about whether mitochondria or phagocytosis came first

  • Promising molecule for treatment of COVID-19

    Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into a drug suitable for treating COVID-19. The molecule is effective against both the new variant and previously identified coronaviruses. The article has been published in the Journal of the American Chemical Society.

  • Unequal knowledge about cardiovascular diseases

    Although many people know what increases the risk of cardiovascular diseases, such as heart attacks, not everyone recognises their own risk factors. This is shown by a new study of 423 Swedes aged 40–70 years, which has now been published in the scientific journal Preventive Medicine Reports.

  • COVID-19 patients may need less oxygen than previously thought

    A new study, led by researchers at Uppsala University, shows that all individual patients suffering from severe COVID-19 may have lower oxygen requirements than was formerly believed. The study was conducted at a Swedish district hospital during the first wave of the pandemic in 2020. The scientists’ methods, as well as their results, may be useful for future planning of health care and resources.

  • Curtailed sleep may alter how intense exercise stresses the heart

    In a new study, participants underwent an intense bout of exercise after both normal sleep and after three nights of curtailed sleep. When they exercised after curtailed sleep, the levels of the heart injury biomarker troponin increased slightly more, compared with when the participants performed exercise in their well-rested condition.

  • Zebrafish and AI replace some mouse experiments in cancer research

    Researchers at Uppsala University have used AI to develop a new method to study brain cancer. The method is based on transplanting tumour cells from patients to fish embryos, followed by observation with AI. The method, which is described in the scientific journal Neuro-Oncology, can partly replace current mouse models for studying tumour growth and treatment.

  • Small measures can be a big help for children of mothers with depression

    Several new studies among Syrian refugee families in Turkey and families with infants in Sweden and Bhutan show that children of mothers in poor mental health risk falling behind in their cognitive development. However, very small changes can suffice to break this correlation and enable the children to return to their normal developmental level. The solutions where the same in all three countries

  • Hunt for the protein TGM1 led to disease discovery

    Searching for the protein TGM1 among patients with autoimmune skin diseases, researchers have identified a separate disease that can be linked to autoimmunity against TGM1. This backward method demonstrates a new way of identifying autoantigens as markers for serious diseases. By letting autoantigens point to the disease, diagnosis and treatment can be facilitated, shows study published in PNAS.

  • Several protein biomarkers protect against disease development

    A comprehensive study from Uppsala University shows that several disease-associated protein biomarkers protect healthy individuals from developing inflammatory diseases. The protective effects are attributed to the proteins’ function in preventing tissue damage, a function that might be very different from the effect in a tissue subjected to chronic or acute inflammation.

  • Blocking inhibits SARS-CoV-2 infection of human cells

    Researchers have developed and used a new method to map interactions on a large scale between human proteins and coronavirus proteins, which has provided valuable new information. In collaborations with others, they show that blocking one of these interactions inhibited infection of human cells by SARS-CoV-2. They also confirmed the interaction between the viral protein and the human protein.

  • Expectations and dopamine can affect outcome of SSRI treatment

    Levels of dopamine and placebo effect can determine whether social anxieties improve when treated with SSRIs. The effect was four times higher for patients with high expectations compared with low expectations, even though the groups received the same medical treatment. Although SSRIs influence levels of serotonin in the brain, the effects on dopamine had the greatest impact for improvement.

  • Pathways to lifelong mental wellbeing in focus at Uppsala Health Summit

    Increasing mental ill health is one of the most urgent public health challenges in the world. The global meeting Uppsala Health Summit, to be held online on 18–21 October, will discuss which preventive measures societies should deploy to better address this troubling trend.

  • How do probiotic bacteria benefit the intestine?

    Interaction between the gut microbiota and the immune system is important for host physiology and susceptibility to disease, but also for the efficacy of e.g., cancer immunotherapies. A multidisciplinary research team have now discovered that specific probiotic bacteria shape the intestinal microbiome by affecting B lymphocytes in the Peyer’s patches to induce, produce and release IgA following t

  • T-cell tests unreliable in establishing previous COVID-19

    Can T-cell tests be used to determine whether people have had COVID-19? Scientists at Uppsala University and Karolinska Institutet have jointly analysed this issue under the aegis of the COMMUNITY study at Danderyd Hospital. Their study is published in the scientific journal PLOS ONE.

  • More effective treatment of Alzheimer’s

    Researchers at Uppsala University have designed new antibodies that might provide more effective treatment methods for Alzheimer’s disease. By designing antibodies that bind even to the smaller aggregates, or clumps, of the amyloid-beta protein, it may be possible to check the progress of the disease. The results presents in Translational Neurodegeneration.

  • Allergic stimulation activates mast cell precursor cells

    Mast cell precursor cells do not just cause an increase in mature mast cells during inflammation, they also play an active role in diseases like asthma. This finding is in a new study by immunology researchers published in the Journal of Allergy and Clinical Immunology. The study also emphasises that precursor cells in general can play an active role in inflammation and challenges the current ide

  • New method used to study how cancer cells are organised

    Changes in individual cancer cells over time may explain why brain tumours develop so differently, and why some cancer cells are resistant to certain treatments. To track the development of cancer cells, researchers at Uppsala University have devised a new method that, in the long term, may make it easier to develop new, effective drug combinations.

Show more